Reader View AI Reader View Earnings call transcript: Replimune Q2 2026 beats EPS as TUDRIQEV launch begins www.investing.com · October 28, 2026 · 12:45 Paywall detected This article has a paywall The publisher blocks direct access to this article. Generate with AI Open link